2. News
  3. Abbott Alere Inc
     Page  1 2 3  ... Next 
Abbott, CamDiab and Ypsomed unveil new automated insulin delivery partnership for people with diabetes27 Apr 2022
Abbott receives U.S. FDA clearance for new cardiac mapping system to improve how doctors treat abnormal heart rhythms15 Jan 2022
Abbott introduces NeuroSphere Virtual Clinic, first-of-its-kind remote neuromodulation patient-care technology in the UK25 Nov 2021
Abbott’s Amplatzer Amulet Occluder shown to offer superior left atrial appendage closure for people at risk of stroke6 Sep 2021
Abbott’s Amplatzer Amulet device approved by FDA to treat people with atrial fibrillation at risk of stroke19 Aug 2021
Abbott receives FDA clearance for its imaging technology using artificial intelligence for vessels in the heart18 Aug 2021
Abbott’s XIENCE stent receives FDA approval for shortest blood thinner course for high bleeding risk patients30 Jun 2021
Abbot receives CE mark for its Panbio rapid Antigen Self-Test, opening access throughout Europe to fast, reliable COVID-19 testing29 Jun 2021
Abbott’s Panbio Rapid Antigen Self-Test receives CE mark, increasing access to fast, reliable COVID-19 testing in the United Kingdom29 Jun 2021
Abbott receives European and Canadian approval for Amplatzer18 Jun 2021